Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis

OBJECTIVE: To evaluate the clinical safety of antenatal and postnatal N-acetylcysteine (NAC) as a neuroprotective agent in maternal chorioamnionitis in a randomized, controlled, double-blinded trial. STUDY DESIGN: Twenty-two mothers >24 weeks gestation presenting within 4 hours of diagnosis of cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Dorothea D., Wiest, Donald B., Mulvihill, Denise M., Hlavacek, Anthony M., Majstoravich, Sarah J., Brown, Truman R., Taylor, Joseph J., Buckley, Jason R., Turner, Robert P., Rollins, Laura Grace, Bentzley, Jessica P., Hope, Kathryn E., Barbour, Andrew B., Lowe, Danielle W., Martin, Renee H., Chang, Eugene Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698030/
https://www.ncbi.nlm.nih.gov/pubmed/26545726
http://dx.doi.org/10.1016/j.jpeds.2015.09.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698030/
https://www.ncbi.nlm.nih.gov/pubmed/26545726
http://dx.doi.org/10.1016/j.jpeds.2015.09.076

Ejemplares similares